{
  "doc_id": "Basic and advanced pleural procedures coding and professional fees update for pulmonologists",
  "title": "Basic and Advanced Pleural Procedures",
  "abstract": "There is an evolution of pleural procedures that involve broadened clinical indication and expanded scope that include advanced diagnostic, therapeutic, and palliative procedures. Finance and clinical professionals have been challenged to understand the indication and coding complexities that accompany these procedures. This article describes the utility of pleural procedures, the appropriate current procedural terminology coding, and necessary modifiers. Coding pearls that help close the knowledge gap between basic and advanced procedures aim to address coding confusion that is prevalent with pleural procedures and the risk of payment denials, potential underpayment, and documentation audits.",
  "content": "Neeraj R. Desai, MD, FCCP; Kim D. French, MHSA, FCCP; and Kevin L. Kovitz, MD, FCCP\nThere is an evolution of pleural procedures that involve broadened clinical indication and expanded scope that include advanced diagnostic, therapeutic, and palliative procedures. Finance and clinical professionals have been challenged to understand the indication and coding complexities that accompany these procedures. This article describes the utility of pleural procedures, the appropriate current procedural terminology coding, and necessary modi fi ers. Coding pearls that help close the knowledge gap between basic and advanced procedures aim to address coding confusion that is prevalent with pleural procedures and the risk of payment denials, potential underpayment, and documentation audits. CHEST 2020; 158(6):2517-2523\nKEY WORDS: coding; pleural procedure; thoracentesis; thoracoscopy\nPleural effusions commonly are encountered in both outpatient and hospital settings. They can be caused by many disease processes that range from infection to malignancy to other in fl ammatory issues to fl uid balance issues. The types of pleural effusion are categorized based on the composition (transudate vs exudate), size, imaging appearance (simple vs complicated) and underlying cause. Malignant pleural effusion is a commonly encountered complication of advanced malignancy. The incidence of malignant pleural effusion is estimated to be > 150,000 cases/year with many cancer types involved of which lung cancer, breast cancer, and lymphoma are the most common. 1 Overall median survival after diagnosis ranges from 3 to 12 months and is dependent on the type of underlying malignancy, tumor characteristics, the extent of disease,\ncomorbidities, and the composition of pleural effusion. 2-6 Basic pleural procedures such as ultrasound scans and thoracentesis are usually the fi rst step in diagnosis or palliation. Medical thoracoscopy or videoassisted thoracoscopic surgery (VATS), chest tubes, and other interventions often are required for persistent or recurrent pleural effusions. In addition to the knowledge of clinical utility of pleural procedures, it is important to become familiar with and understand current procedural terminology (CPT) 7 coding, necessary modi fi ers, and associated work relative value unit (wRVU). 7,8\nUltrasonography has a higher sensitivity in the detection of pleural effusion than chest radiography as a screening tool. 9,10 This aids in the assessment of the\nABBREVIATIONS: CPT = current procedural terminology; VATS = video-assisted thoracoscopic surgery; wRVU = work relative value unit AFFILIATIONS: From the Chicago Chest Center (Drs Desai and Kovitz and Ms French), Elk Grove Village, IL; AMITA Health (Drs Desai and Kovitz and Ms French), Lisle, IL; and Department of Medicine (Drs Desai and Kovitz), Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, Chicago, IL.\nCORRESPONDENCE TO: Neeraj R. Desai, MD, FCCP, Chicago Chest Center and AMITA Health, 800 Biester fi eld Rd, Elk Grove Village, IL 60007; e-mail: desai@chestcenter.com\nCopyright 1 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.\nDOI: https://doi.org/10.1016/j.chest.2020.08.2070\nthickness of the lining of the pleura and, when pleural malignancy is suspected, can identify pleural metastases. Immediate preprocedural ultrasonography has become the standard of care to help to identify the appropriate site for drainage, to avoid septations, and to decrease the rate of complications. 11-16\nFor ultrasound imaging of the pleural space to determine that there is resolution of fl uid or that there is no pneumothorax and that is not associated with another procedure, the code 76604 for chest scan only is used. If ultrasound guidance is used to guide a catheter or needle insertion or for guiding the thoracoscopy entry site, the code 75989 is used along with the procedure code. The use of ultrasound or other image guidance (ie, fl uoroscopy, CT scanning) codes apply to the other procedures in the article, unless otherwise stated. In each case, append a 26 modi fi er if the ultrasound unit is supplied by the facility so as to separate one ' s professional billing from the facility ' s reimbursement. Note that an ultrasound image from the procedure must be saved in some form, printed or digital, to bill for the service.\nThoracentesis is the most basic of pleural procedures. Pleural effusions are common and may require sampling or even complete drainage for diagnosis and therapeutic purposes. It is performed with a needle or catheter that is placed into the desired pleural space with fl uid removed by gravity, hand pumping, or vacuum. Ultrasound examination may be performed immediately before the procedure for direct guidance and to ensure that the appropriate entry point is identi fi ed and marked. Pleural fl uid aspiration is carried out with the use of aseptic precautions. There is no increased risk of bleeding due to mild-tomoderate coagulopathy and thrombocytopenia. Studies have also shown no increase in the risk of bleeding with uncorrected coagulopathy and other bleeding risks such as clopidogrel use, renal disease, and thrombocytopenia. 17,18\nThe key to coding for this procedure is that the needle or catheter is removed at the end of the procedure. Further, the codes used account for whether ultrasound guidance is used. The code of 32554 is appropriate when there is no ultrasound guidance; the code 32555 is appropriate when ultrasound guidance is used. Note that ultrasound guidance has been included or ' bundled ' into the code\nso that, when used, it is not billed separately. In the occasional situation when ultrasound guidance prior to drainage determines that there is insuf fi cient fl uid for drainage and only ultrasound imaging is done, the code 76604 for chest scan only is used (append a 26 modi fi er if the ultrasound unit is supplied by the facility so as to separate one ' s professional component from the total reimbursement).\nWhen pleural fl uid evaluation is not diagnostic in a patient with suspected malignant pleural effusion or pleural TB, a pleural biopsy is considered. A blind closed pleural biopsy is performed with the use of an Abrams or Cope needle. Blind closed pleural biopsies have relatively low sensitivity due to the lower yield at early stage, distribution of tumor, and possibly operator inexperience. 1 Despite the limitations, practitioners around the world continue to perform the procedure because it requires limited experience and the cost of equipment, team, and resources is lower than medical thoracoscopy. 19\nSampling of the pleura was done historically as a closed pleural biopsy with the use of a Cope or Abrams needle. Although this is less frequently done, the code 32400 is used. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section, if used.\nChest tubes are used when the pleural space needs ongoing evacuation of air or fl uid. These are distinct from thoracentesis in that the tube or catheter is inserted into the pleural space and left in place. These fall into three categories. The classic chest tube/tube thoracostomy procedure involves an incision and introduction of an instrument or even a fi nger into the pleural space to assist placement of the tube. This is considered the most invasive and is valued as such. The code 32551 is used. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section. The option of inserting a tube over a wire is less valued because it is considered less invasive. It is considered a catheter rather than a tube and has two associated codes. The code 32556 is used if the procedure is done without image guidance; the code 32557 is used if image guidance is part of the procedure. Again, the image guidance is ' bundled ' if it is part of the procedure and not billed separately.\nRemoval of these tubes is not separately billable and is simply part of the evaluation and management work done on the day of removal.\nIndwelling pleural catheters are used for chronic drainage. They are tunneled catheters that allow repeated access to pleural drainage. They are used most often for the management of symptomatic malignant pleural effusions but have been used for benign underlying conditions as well. There are two distinct codes for this procedure, one for insertion and one for removal. The code 32550 is used for insertion of the catheter. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section if used. The physician who places these should be aware of the insurance coverage for the home supplies required, which may vary by carrier and impact the home care options or ability of the patient to comply.\nWhen indwelling catheters were fi rst introduced, the assumption was that they would be in place inde fi nitely as a palliative measure. Subsequently, the realization was that the catheters were sometimes removed and often removed by a different provider than the one who had placed the tube; therefore, a removal code was developed for catheter removal, 32552.\nMedical thoracoscopy (also known as pleuroscopy) was popularized in 1910 by a Swedish internist, Hans Christian Jacobaeus. 20,21 The evolution of medical thoracoscopy into VATS has allowed for an even greater range of therapeutic solutions. Medical thoracoscopy differs in some ways from VATS in that it is performed in an endoscopy room or OR, typically with local anesthesia and/or moderate sedation and single port and by a pulmonologist or surgeon. Both medical thoracoscopy and VATS allow for direct visualization and biopsy of suspicious pleural abnormalities, such as nodularity, masses, and thickening. Due to lower than accepted diagnostic rates for blind closed pleural biopsy, with or without pleural fl uid cytologic evidence, a visualized directed pleural biopsy via medical thoracoscopy or VATS may be needed. 22 Medical thoracoscopy with local anesthetic has low of complication and mortality rates, despite the invasiveness of the procedure. Mortality rate related to\nmedical thoracoscopy alone is approximately 0.34%, as reported by Rahman et al, 22 and may be linked to complications associated with talc. Major complications that included empyema, hemorrhage, port site tumor growth, bronchopleural fi stula, postoperative pneumothorax or air leak, and pneumonia were reported in 1.8% of cases. 23 Thoracoscopy is an invaluable diagnostic tool for the diagnosis of pleural mesothelioma, especially considering the even lower diagnostic rate of pleural fl uid cytologic evidence alone (26% to 32%). 21,24,25\nThe following selection codes relate to the more common of the minimally invasive procedures. The code 32601 for diagnostic thoracoscopy is used to evaluate the pleural space, lungs, pericardial sac, or mediastinum, but there is no biopsy. A diagnostic thoracoscopy with a biopsy uses the code 32609. If pleurodesis is done as part of the procedure, the code 32650 is used. Partial decortication performed during thoracoscopy uses the code 32651; if there is removal of a foreign body or fi brin deposits, the code 32653 is used.\nThe codes 32650, 32651, and 32653 are categorized as ' surgical ' rather than ' diagnostic ' procedures. Diagnostic thoracoscopy has a 0-day global period; whereas, surgical thoracoscopy has a 90-day global period. That is, subsequent care for the diagnostic procedures, whether related to the procedure or not, is separately billable immediately after the procedure, whereas subsequent care for the surgical patients related to the procedure is inherent or ' bundled ' into the reimbursement for the procedure and is not separately billable for 90 days. This includes management of an indwelling pleural catheter placed during the same ' surgical ' thoracoscopy.\nPleurodesis is the fusion of the parietal and visceral pleura, which leads to obliteration of the pleural space and prevents accumulation of pleural effusion. The exact mechanism of pleurodesis is unclear, but it is suspected to be due to in fl ammation/ fi brosis via transforming growth factor beta. 26\nChemical pleurodesis, the instillation of a substance via a tube into the pleural space in an attempt to obliterate all or some of the space to prevent recurrence of fl uid, is coded as 32560. This code is used regardless of the\nchemical used. If a pleural tube or catheter is placed on the same day, modi fi er 51 is used to indicate the separate procedure. If done as part of a thoracoscopy, it is coded as 32650 and becomes a ' surgical ' thoracoscopy with a global period.\nAt times, there is a need to break up loculations in the pleural space to improve drainage, especially in a setting of complicated parapneumonic effusion, empyema, or clogged indwelling pleural catheter.\nOn the initial day of instillation of a fi brinolytic agent, the code 32561 is used. On each subsequent day of fi brinolytic agent instillation, the code 32562 is used. A 25 modi fi er is appended to an evaluation and management encounter on the same day, indicating a distinct same-day procedure. Note, although fi brinolysis protocols call for twice-a-day agent instillation, the code can be billed only once per calendar day.\nTable 1 provides the CPT code descriptors for basic and advanced pleural procedures and their associated wRVUs\nThe global surgical package, also called global surgery, includes all the necessary services normally furnished by a surgeon before, during, and after a procedure. Medicare payment for a surgical procedure includes the preoperative, intraoperative, and postoperative services that are performed routinely by the surgeon or by members of the same group with the same specialty. Physicians in the same group practice who are in the same specialty must bill and be paid as though they were a single physician. 27\nThere are three types of global surgical packages based on the number of postoperative days: (1) The 0-day postoperative period (endoscopies and some minor procedures) has no preoperative period and no postoperative days; the visit on the day of procedure is generally not payable as a separate service; (2) the 10day postoperative period (other minor procedures) has no preoperative period; the visit on the day of the procedure is generally not payable as a separate service, and the total global period is 11 days (count the day of the surgery and the 10 days immediately after the day of\nwRVU 1â„4 work relative value unit.\nthe surgery); and (3) the 90-day postoperative period (major procedures) has 1 preoperative day included; the day of the procedure is generally not payable as a separate service, and the total global period is 92 days (count 1 day before the day).\nCodes with ' 000 ' are endoscopies or some minor surgical procedures (zero day postoperative period). Codes with ' 010 ' are other minor procedures (10-day postoperative period). Codes with ' 090 ' are major surgeries (90-day postoperative period). Table 2 lists thoracoscopy procedures performed by pulmonologists where the global surgical package would be considered, services that are included in the global surgery package and the services that can be billed separately.\nAttention needs to be paid to the use of appropriate modi fi ers. When a procedure is performed on the same day as an evaluation and management encounter, a 25 modi fi er is appended to the evaluation and\nmanagement encounter, thereby demonstrating a distinct service separate from the procedure.\nExample: A consultation is performed on a inpatient for dyspnea. The patient has multiple comorbidities, and a moderately complex consultation is done (evaluation and management CPT code 99254). As part of the evaluation, it is decided that there is a pleural effusion that needs drainage the same day. With the use of ultrasound guidance, a thoracentesis is performed by the same provider (code 32555). When you have an evaluation and management encounter and a procedure on the same day, append modi fi er 25 to the evaluation and management code (99254-25 and 32555).\nModi fi ers 51 and 59 both are used when multiple services are performed during a single encounter, but they serve different purposes. Although modi fi er 51 and 59 both apply to additional procedures performed on the same date of service as the primary procedure, modi fi er 51 differs from modi fi er 59 in that it applies to\nMedicare includes the following services in the global surgery payment when provided in addition to the surgery:\nPreoperative visits after the decision is made to operate\nIntraoperative services that are normally a usual and necessary part of a surgical procedure\nAll additional medical or surgical services required of the surgeon during the postoperative period of the surgery because of complications that do not require additional trips to the operating room.\nFollow-up visits during the postoperative period of the surgery that are related to recovery from the surgery\nPostsurgical pain management by the surgeon\nSupplies, except for those identi fi ed as exclusions\nMiscellaneous services, such as dressing changes, local incision care, removal of operative pack, removal of cutaneous sutures and staples, lines, wires, tubes, drains, casts, and splints; insertion, irrigation, and removal of urinary catheters, routine peripheral IV lines, nasogastric and rectal tubes; and changes and removal of tracheostomy tubes\nThe following services are not included in the global surgical payment and may be billed and paid for separately:\nInitial consultation or evaluation of the problem by the surgeon to determine the need for major surgeries. This is billed separately using the modi fi er ' -57 ' (Decision for Surgery). This visit may be billed separately only for major surgical procedures.\nTreatment for postoperative complications that require a return trip to the OR. An OR, for this purpose, is de fi ned as a place of service speci fi cally equipped and staffed for the sole purpose of performing procedures. The term includes a cardiac catheterization suite, a laser suite, and an endoscopy suite. It does not include a patient ' s room, a minor treatment room, a recovery room, or an ICU (unless the patient ' s condition was so critical that there would be insuf fi cient time for transportation to an OR).\nIf a less extensive procedure fails and a more extensive procedure is required, the second procedure is payable separately.\nprocedures that may be expected more commonly to be performed during the same session.\nIf the procedure is done as part of multiple procedures at the same time or day, a 51 modi fi er is used to note the distinct procedure, which indicates that multiple procedures were performed at the same session. That is, it applies to different procedures performed at the same session (example: thoracentesis and bronchoscopy on the same day).\nModi fi er 59 is used for a distinct procedural service. Modi fi er 59 indicates that a procedure is separate and distinct from another procedure on the same date of service. Typically, this modi fi er is applied to a procedure code that ordinarily is not paid separately from the fi rst procedure but should be paid per the speci fi cs of the situation. Example: Modi fi er 59 is applied when separate biopsies are performed on different anatomic sites or lesions during the same procedure or separate incision or different session\nThe 26 modi fi er is used when one needs to separate out the professional from the facility-based technical component of a procedure. Examples used in this section are of ultrasound imaging where clinical decisions are interpreted and made based on the image; however, the facility owns the equipment.\nModi fi er 22 is used for a procedure that is more complex than typical and represents substantially increased time to perform the service. It rarely is reimbursed and is carrier-dependent.\nModi fi er 50 is used for bilateral procedures that are not described inherently as bilateral. This would apply to bilateral indwelling pleural catheter and bilateral chest tubes as examples. Table 3 provides the CPT code descriptors for moderate sedation and common modi fi ers used for pleural procedures and their associated wRVUs\nIf moderate sedation is used for any pleural procedure and is administered under the direction of the operator or by a member of the operator ' s practice, there are time-based codes applied. For patients $ 5 years old, the fi rst 15 minutes of sedation is coded as 99152. A minimum time of 10 minutes must be reached to use this code. For each additional 15 minutes (a minimum of 8 minutes), the code 99153 is used. Note that the physician wRVU of 0.25 is for the fi rst 15 minutes, and the subsequent intervals are only practice expense. Further, the time is from the fi rst infusion of sedation to the end of 1:1 operator presence and may overlap but is not the same as procedure time. These codes do not apply if the sedation is administered by a practitioner from a separate group or specialty (ie, anesthesiologist).\nAlthough the clinical utility of pleural procedures is accepted more widely, the coding remains confusing due\nN/A = not applicable. See Table 1 legend for expansion of other abbreviation.\na Note that the physician wRVU of 0.25 is for the fi rst 15 minutes, and the subsequent intervals are only practice expense.\nto procedure complexity and updated coding requirements. The range of procedures discussed may be performed as stand-alone procedures but more commonly are performed along with advanced pulmonary or interventional pulmonary procedures. With improved technology, ef fi ciency, and ef fi cacy of performing multiple procedures in the same setting, it becomes critical to thoroughly understand the clinical, coding, and fi nancial implications of these procedures. Appropriately optimizing facility and physician reimbursement is integral to the assimilation of pleural procedures into comprehensive pulmonary and oncology programs.\nFinancial/non fi nancial disclosures: The authors have reported to CHEST the following: N. R. D. receives funding from Veran Medical, Level Ex, Boston scienti fi c (consultant). None declared (K. D. F. and K. L. K.).\n1. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med . 2000;162(5):1987-2001.\n2. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; Group BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii32-ii40.\n3. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest . 2000;117(1):7378.\n4. Bielsa S, Salud A, Martinez M, et al. Prognostic signi fi cance of pleural fl uid data in patients with malignant effusion. Eur J Intern Med . 2008;19(5):334-339.\n5. Pilling JE, Dusmet ME, Ladas G, Goldstraw P. Prognostic factors for survival after surgical palliation of malignant pleural effusion. J Thorac Oncol . 2010;5(10):1544-1550.\n6. Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax . 2014;69(12):1098-1104.\n7. ( AMA) AMA. CPT 0 (Current Procedural Terminology). In: https://www.ama-assn.org/amaone/cpt-current-proceduralterminology. Accessed May 13, 2020.\n8. ( AMA) AMA. RVS Update Committee (RUC): RBRVS overview. https://www.ama-assn.org/about/rvs-update-committee-ruc/rbrvsoverview. Accessed May 31, 2020.\n9. Youse fi fard M, Baikpour M, Ghelichkhani P, et al. Screening performance characteristic of ultrasonography and radiography in detection of pleural effusion; a meta-analysis. Emergency . 2016;4(1): 1-10.\n10. Eibenberger KL, Dock WI, Ammann ME, Dorffner R, Hormann MF, Grabenwoger F. Quanti fi cation of pleural effusions: sonography versus radiography. Radiology . 1994;191(3):681-684.\n11. Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest . 2003;123(2):436-441.\n12. Raptopoulos V, Davis LM, Lee G, Umali C, Lew R, Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol . 1991;156(5):917-920.\n13. Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med . 2010;170(4):332-339.\n14. Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA, Ryu JH. Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound . 2005;33(9):442-446.\n15. Sachdeva A, Shepherd RW, Lee HJ. Thoracentesis and thoracic ultrasound: state of the art in 2013. Clin Chest Med . 2013;34(1):1-9.\n16. Cantey EP, Walter JM, Corbridge T, Barsuk JH. Complications of thoracentesis: incidence, risk factors, and strategies for prevention. Curr Opin Pulm Med . 2016;22(4):378-385.\n17. Puchalski JT, Argento AC, Murphy TE, Araujo KL, Pisani MA. The safety of thoracentesis in patients with uncorrected bleeding risk. Ann Am Thorac Soc . 2013;10(4):336-341.\n18. Zalt MB, Bechara RI, Parks C, Berkowitz DM. Effect of routine clopidogrel use on bleeding complications after ultrasound-guided thoracentesis. J Bronchology Interv Pulmonol . 2012;19(4):284-287.\n19. Baumann MH. Closed pleural biopsy: not dead yet! Chest . 2006;129(6):1398-1400.\n20. Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical-in the management of pleural diseases. J Thorac Dis . 2015;7(suppl4):S339S351.\n21. Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis . 2017;9(suppl10): S1111-S1122.\n22. Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii54-ii60.\n23. Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest . 2005;127(3):909-915.\n24. Hooper C, Lee YC, Maskell N; Group BTS Pleural Disease Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii4-ii17.\n25. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fl uid in the diagnosis of malignant mesothelioma. Chest . 1997;111(1):106-109.\n26. Shojaee S, Voelkel N, Farkas L, de Wit M, Lee HJ. Transforming growth factor-beta1 rise in pleural fl uid after tunneled pleural catheter placement: pilot study. J Bronchology Interv Pulmonol . 2013;20(4):304-308.\n27. CMS. Global Surgery Booklet. https://www.cms.gov/Regulationsand-Guidance/Guidance/Manuals/Downloads/clm104c12.pdf; 2018. Accessed May 30, 2020.\n\n## Tables\n\n**{'cref': '#/texts/51'}**\n\n| Current Procedural Terminology Code | Code Description | wRVU |\n| --- | --- | --- |\n| 32554 | Thoracentesis, needle or catheter, aspiration of the pleural space; without imaging guidance | 1.82 |\n| 32555 | Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance | 2.27 |\n| 32556 | Pleural drainage, percutaneous, with insertion of indwelling catheter; without imaging guidance | 2.50 |\n| 32557 | Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance | 3.12 |\n| 32551 | Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure) | 3.04 |\n| 32550 | Insertion of indwelling tunneled pleural catheter with cuff | 3.92 |\n| 32552 | Removal of indwelling tunneled pleural catheter with cuff | 2.53 |\n| 32601 | Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy | 5.50 |\n| 32609 | Thoracoscopy; with biopsy(ies) of pleura | 4.58 |\n| 32650 | Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical) | 10.83 |\n| 32651 | Thoracoscopy, surgical; with partial pulmonary decortication | 18.78 |\n| 32653 | Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit | 18.17 |\n| 32561 | Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); initial day | 1.39 |\n| 32562 | Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); subsequent day | 1.24 |\n| 32400 | Biopsy, pleura, percutaneous needle | 1.76 |\n\n**{'cref': '#/texts/68'}**\n\n| CPT Code | Code Description | Global Period |\n| --- | --- | --- |\n| 32601 | Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy | 000 |\n| 32609 | Thoracoscopy; with biopsy(ies) of pleura | 000 |\n| 32650 | Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical) | 090 |\n| 32651 | Thoracoscopy, surgical; with partial pulmonary decortication | 090 |\n| 32653 | Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit | 090 |\n\n**{'cref': '#/texts/90'}**\n\n| Current Procedural Terminology Code | Description | wRVU |\n| --- | --- | --- |\n| 99152 | Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age $ 5 years | 0.25 |\n| 99153 | Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | N/A a |\n| Modi fi ers |  |  |\n| 26 | Modi fi er applied to 76604, 75989 if facility-owned ultrasound equipment used |  |\n| 25 | Modi fi er applied to same day ' Evaluation and Management ' |  |\n| 51 | Modi fi er for ' Additional Procedures ' done at same time |  |\n| 59 | Modi fi er for ' Distinct Procedural Service ' |  |",
  "year": 2020,
  "h_level": "H1",
  "metadata": {
    "book": "",
    "journal": "Chest",
    "year": 2020,
    "authors": [
      "Neeraj R. Desai",
      "Kim D. French",
      "Kevin L. Kovitz"
    ],
    "doi": "10.1016/j.chest.2020.08.2070",
    "pmid": "",
    "volume": "158",
    "issue": "6",
    "pages": "2517-2523",
    "authority_tier": "A4",
    "evidence_level": "H1",
    "precedence": 0.587,
    "domain": [
      "coding_billing",
      "lung_volume_reduction",
      "technology_navigation"
    ],
    "doc_type": "systematic_review",
    "aliases": [
      "spiration",
      "enb"
    ],
    "temporal": {
      "valid_from": "2020-01-01",
      "valid_until": "2022-12-31",
      "last_seen_year": 2020
    },
    "original_file": "Basic and advanced pleural procedures coding and professional fees update for pulmonologists.json"
  },
  "sections": [
    {
      "title": "asic and Advanced Pleural Procedures Coding and Professional Fees Update for Pulmonologists",
      "content": "Neeraj R. Desai, MD, FCCP; Kim D. French, MHSA, FCCP; and Kevin L. Kovitz, MD, FCCP\nThere is an evolution of pleural procedures that involve broadened clinical indication and expanded scope that include advanced diagnostic, therapeutic, and palliative procedures. Finance and clinical professionals have been challenged to understand the indication and coding complexities that accompany these procedures. This article describes the utility of pleural procedures, the appropriate current procedural terminology coding, and necessary modi fi ers. Coding pearls that help close the knowledge gap between basic and advanced procedures aim to address coding confusion that is prevalent with pleural procedures and the risk of payment denials, potential underpayment, and documentation audits. CHEST 2020; 158(6):2517-2523\nKEY WORDS: coding; pleural procedure; thoracentesis; thoracoscopy\nPleural effusions commonly are encountered in both outpatient and hospital settings. They can be caused by many disease processes that range from infection to malignancy to other in fl ammatory issues to fl uid balance issues. The types of pleural effusion are categorized based on the composition (transudate vs exudate), size, imaging appearance (simple vs complicated) and underlying cause. Malignant pleural effusion is a commonly encountered complication of advanced malignancy. The incidence of malignant pleural effusion is estimated to be > 150,000 cases/year with many cancer types involved of which lung cancer, breast cancer, and lymphoma are the most common. 1 Overall median survival after diagnosis ranges from 3 to 12 months and is dependent on the type of underlying malignancy, tumor characteristics, the extent of disease,\ncomorbidities, and the composition of pleural effusion. 2-6 Basic pleural procedures such as ultrasound scans and thoracentesis are usually the fi rst step in diagnosis or palliation. Medical thoracoscopy or videoassisted thoracoscopic surgery (VATS), chest tubes, and other interventions often are required for persistent or recurrent pleural effusions. In addition to the knowledge of clinical utility of pleural procedures, it is important to become familiar with and understand current procedural terminology (CPT) 7 coding, necessary modi fi ers, and associated work relative value unit (wRVU). 7,8",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "hest Ultrasonography",
      "content": "Ultrasonography has a higher sensitivity in the detection of pleural effusion than chest radiography as a screening tool. 9,10 This aids in the assessment of the\nABBREVIATIONS: CPT = current procedural terminology; VATS = video-assisted thoracoscopic surgery; wRVU = work relative value unit AFFILIATIONS: From the Chicago Chest Center (Drs Desai and Kovitz and Ms French), Elk Grove Village, IL; AMITA Health (Drs Desai and Kovitz and Ms French), Lisle, IL; and Department of Medicine (Drs Desai and Kovitz), Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, Chicago, IL.\nCORRESPONDENCE TO: Neeraj R. Desai, MD, FCCP, Chicago Chest Center and AMITA Health, 800 Biester fi eld Rd, Elk Grove Village, IL 60007; e-mail: desai@chestcenter.com\nCopyright 1 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.\nDOI: https://doi.org/10.1016/j.chest.2020.08.2070\n\nthickness of the lining of the pleura and, when pleural malignancy is suspected, can identify pleural metastases. Immediate preprocedural ultrasonography has become the standard of care to help to identify the appropriate site for drainage, to avoid septations, and to decrease the rate of complications. 11-16",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "For ultrasound imaging of the pleural space to determine that there is resolution of fl uid or that there is no pneumothorax and that is not associated with another procedure, the code 76604 for chest scan only is used. If ultrasound guidance is used to guide a catheter or needle insertion or for guiding the thoracoscopy entry site, the code 75989 is used along with the procedure code. The use of ultrasound or other image guidance (ie, fl uoroscopy, CT scanning) codes apply to the other procedures in the article, unless otherwise stated. In each case, append a 26 modi fi er if the ultrasound unit is supplied by the facility so as to separate one ' s professional billing from the facility ' s reimbursement. Note that an ultrasound image from the procedure must be saved in some form, printed or digital, to bill for the service.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "horacentesis",
      "content": "Thoracentesis is the most basic of pleural procedures. Pleural effusions are common and may require sampling or even complete drainage for diagnosis and therapeutic purposes. It is performed with a needle or catheter that is placed into the desired pleural space with fl uid removed by gravity, hand pumping, or vacuum. Ultrasound examination may be performed immediately before the procedure for direct guidance and to ensure that the appropriate entry point is identi fi ed and marked. Pleural fl uid aspiration is carried out with the use of aseptic precautions. There is no increased risk of bleeding due to mild-tomoderate coagulopathy and thrombocytopenia. Studies have also shown no increase in the risk of bleeding with uncorrected coagulopathy and other bleeding risks such as clopidogrel use, renal disease, and thrombocytopenia. 17,18",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "The key to coding for this procedure is that the needle or catheter is removed at the end of the procedure. Further, the codes used account for whether ultrasound guidance is used. The code of 32554 is appropriate when there is no ultrasound guidance; the code 32555 is appropriate when ultrasound guidance is used. Note that ultrasound guidance has been included or ' bundled ' into the code\nso that, when used, it is not billed separately. In the occasional situation when ultrasound guidance prior to drainage determines that there is insuf fi cient fl uid for drainage and only ultrasound imaging is done, the code 76604 for chest scan only is used (append a 26 modi fi er if the ultrasound unit is supplied by the facility so as to separate one ' s professional component from the total reimbursement).",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "lind Closed Pleural Biopsy",
      "content": "When pleural fl uid evaluation is not diagnostic in a patient with suspected malignant pleural effusion or pleural TB, a pleural biopsy is considered. A blind closed pleural biopsy is performed with the use of an Abrams or Cope needle. Blind closed pleural biopsies have relatively low sensitivity due to the lower yield at early stage, distribution of tumor, and possibly operator inexperience. 1 Despite the limitations, practitioners around the world continue to perform the procedure because it requires limited experience and the cost of equipment, team, and resources is lower than medical thoracoscopy. 19",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "Sampling of the pleura was done historically as a closed pleural biopsy with the use of a Cope or Abrams needle. Although this is less frequently done, the code 32400 is used. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section, if used.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "hest Tubes",
      "content": "Chest tubes are used when the pleural space needs ongoing evacuation of air or fl uid. These are distinct from thoracentesis in that the tube or catheter is inserted into the pleural space and left in place. These fall into three categories. The classic chest tube/tube thoracostomy procedure involves an incision and introduction of an instrument or even a fi nger into the pleural space to assist placement of the tube. This is considered the most invasive and is valued as such. The code 32551 is used. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section. The option of inserting a tube over a wire is less valued because it is considered less invasive. It is considered a catheter rather than a tube and has two associated codes. The code 32556 is used if the procedure is done without image guidance; the code 32557 is used if image guidance is part of the procedure. Again, the image guidance is ' bundled ' if it is part of the procedure and not billed separately.\n\nRemoval of these tubes is not separately billable and is simply part of the evaluation and management work done on the day of removal.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "ndwelling Pleural Catheter Placement",
      "content": "Indwelling pleural catheters are used for chronic drainage. They are tunneled catheters that allow repeated access to pleural drainage. They are used most often for the management of symptomatic malignant pleural effusions but have been used for benign underlying conditions as well. There are two distinct codes for this procedure, one for insertion and one for removal. The code 32550 is used for insertion of the catheter. Image guidance codes are applied as described in the ' Chest Ultrasonography ' section if used. The physician who places these should be aware of the insurance coverage for the home supplies required, which may vary by carrier and impact the home care options or ability of the patient to comply.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "ndwelling Pleural Catheter Removal",
      "content": "When indwelling catheters were fi rst introduced, the assumption was that they would be in place inde fi nitely as a palliative measure. Subsequently, the realization was that the catheters were sometimes removed and often removed by a different provider than the one who had placed the tube; therefore, a removal code was developed for catheter removal, 32552.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "edical Thoracoscopy",
      "content": "Medical thoracoscopy (also known as pleuroscopy) was popularized in 1910 by a Swedish internist, Hans Christian Jacobaeus. 20,21 The evolution of medical thoracoscopy into VATS has allowed for an even greater range of therapeutic solutions. Medical thoracoscopy differs in some ways from VATS in that it is performed in an endoscopy room or OR, typically with local anesthesia and/or moderate sedation and single port and by a pulmonologist or surgeon. Both medical thoracoscopy and VATS allow for direct visualization and biopsy of suspicious pleural abnormalities, such as nodularity, masses, and thickening. Due to lower than accepted diagnostic rates for blind closed pleural biopsy, with or without pleural fl uid cytologic evidence, a visualized directed pleural biopsy via medical thoracoscopy or VATS may be needed. 22 Medical thoracoscopy with local anesthetic has low of complication and mortality rates, despite the invasiveness of the procedure. Mortality rate related to\nmedical thoracoscopy alone is approximately 0.34%, as reported by Rahman et al, 22 and may be linked to complications associated with talc. Major complications that included empyema, hemorrhage, port site tumor growth, bronchopleural fi stula, postoperative pneumothorax or air leak, and pneumonia were reported in 1.8% of cases. 23 Thoracoscopy is an invaluable diagnostic tool for the diagnosis of pleural mesothelioma, especially considering the even lower diagnostic rate of pleural fl uid cytologic evidence alone (26% to 32%). 21,24,25",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "The following selection codes relate to the more common of the minimally invasive procedures. The code 32601 for diagnostic thoracoscopy is used to evaluate the pleural space, lungs, pericardial sac, or mediastinum, but there is no biopsy. A diagnostic thoracoscopy with a biopsy uses the code 32609. If pleurodesis is done as part of the procedure, the code 32650 is used. Partial decortication performed during thoracoscopy uses the code 32651; if there is removal of a foreign body or fi brin deposits, the code 32653 is used.\nThe codes 32650, 32651, and 32653 are categorized as ' surgical ' rather than ' diagnostic ' procedures. Diagnostic thoracoscopy has a 0-day global period; whereas, surgical thoracoscopy has a 90-day global period. That is, subsequent care for the diagnostic procedures, whether related to the procedure or not, is separately billable immediately after the procedure, whereas subsequent care for the surgical patients related to the procedure is inherent or ' bundled ' into the reimbursement for the procedure and is not separately billable for 90 days. This includes management of an indwelling pleural catheter placed during the same ' surgical ' thoracoscopy.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "leurodesis",
      "content": "Pleurodesis is the fusion of the parietal and visceral pleura, which leads to obliteration of the pleural space and prevents accumulation of pleural effusion. The exact mechanism of pleurodesis is unclear, but it is suspected to be due to in fl ammation/ fi brosis via transforming growth factor beta. 26",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "Chemical pleurodesis, the instillation of a substance via a tube into the pleural space in an attempt to obliterate all or some of the space to prevent recurrence of fl uid, is coded as 32560. This code is used regardless of the\nchemical used. If a pleural tube or catheter is placed on the same day, modi fi er 51 is used to indicate the separate procedure. If done as part of a thoracoscopy, it is coded as 32650 and becomes a ' surgical ' thoracoscopy with a global period.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "leurolysis",
      "content": "At times, there is a need to break up loculations in the pleural space to improve drainage, especially in a setting of complicated parapneumonic effusion, empyema, or clogged indwelling pleural catheter.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oding Pearls",
      "content": "On the initial day of instillation of a fi brinolytic agent, the code 32561 is used. On each subsequent day of fi brinolytic agent instillation, the code 32562 is used. A 25 modi fi er is appended to an evaluation and management encounter on the same day, indicating a distinct same-day procedure. Note, although fi brinolysis protocols call for twice-a-day agent instillation, the code can be billed only once per calendar day.\nTable 1 provides the CPT code descriptors for basic and advanced pleural procedures and their associated wRVUs",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "lobal Surgical Package",
      "content": "The global surgical package, also called global surgery, includes all the necessary services normally furnished by a surgeon before, during, and after a procedure. Medicare payment for a surgical procedure includes the preoperative, intraoperative, and postoperative services that are performed routinely by the surgeon or by members of the same group with the same specialty. Physicians in the same group practice who are in the same specialty must bill and be paid as though they were a single physician. 27\nThere are three types of global surgical packages based on the number of postoperative days: (1) The 0-day postoperative period (endoscopies and some minor procedures) has no preoperative period and no postoperative days; the visit on the day of procedure is generally not payable as a separate service; (2) the 10day postoperative period (other minor procedures) has no preoperative period; the visit on the day of the procedure is generally not payable as a separate service, and the total global period is 11 days (count the day of the surgery and the 10 days immediately after the day of\nwRVU 1â„4 work relative value unit.\n\nthe surgery); and (3) the 90-day postoperative period (major procedures) has 1 preoperative day included; the day of the procedure is generally not payable as a separate service, and the total global period is 92 days (count 1 day before the day).\nCodes with ' 000 ' are endoscopies or some minor surgical procedures (zero day postoperative period). Codes with ' 010 ' are other minor procedures (10-day postoperative period). Codes with ' 090 ' are major surgeries (90-day postoperative period). Table 2 lists thoracoscopy procedures performed by pulmonologists where the global surgical package would be considered, services that are included in the global surgery package and the services that can be billed separately.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "odi fi ers",
      "content": "Attention needs to be paid to the use of appropriate modi fi ers. When a procedure is performed on the same day as an evaluation and management encounter, a 25 modi fi er is appended to the evaluation and\nmanagement encounter, thereby demonstrating a distinct service separate from the procedure.\nExample: A consultation is performed on a inpatient for dyspnea. The patient has multiple comorbidities, and a moderately complex consultation is done (evaluation and management CPT code 99254). As part of the evaluation, it is decided that there is a pleural effusion that needs drainage the same day. With the use of ultrasound guidance, a thoracentesis is performed by the same provider (code 32555). When you have an evaluation and management encounter and a procedure on the same day, append modi fi er 25 to the evaluation and management code (99254-25 and 32555).\nModi fi ers 51 and 59 both are used when multiple services are performed during a single encounter, but they serve different purposes. Although modi fi er 51 and 59 both apply to additional procedures performed on the same date of service as the primary procedure, modi fi er 51 differs from modi fi er 59 in that it applies to\nMedicare includes the following services in the global surgery payment when provided in addition to the surgery:\nPreoperative visits after the decision is made to operate\nIntraoperative services that are normally a usual and necessary part of a surgical procedure\nAll additional medical or surgical services required of the surgeon during the postoperative period of the surgery because of complications that do not require additional trips to the operating room.\nFollow-up visits during the postoperative period of the surgery that are related to recovery from the surgery\nPostsurgical pain management by the surgeon\nSupplies, except for those identi fi ed as exclusions\nMiscellaneous services, such as dressing changes, local incision care, removal of operative pack, removal of cutaneous sutures and staples, lines, wires, tubes, drains, casts, and splints; insertion, irrigation, and removal of urinary catheters, routine peripheral IV lines, nasogastric and rectal tubes; and changes and removal of tracheostomy tubes\nThe following services are not included in the global surgical payment and may be billed and paid for separately:\nInitial consultation or evaluation of the problem by the surgeon to determine the need for major surgeries. This is billed separately using the modi fi er ' -57 ' (Decision for Surgery). This visit may be billed separately only for major surgical procedures.\nTreatment for postoperative complications that require a return trip to the OR. An OR, for this purpose, is de fi ned as a place of service speci fi cally equipped and staffed for the sole purpose of performing procedures. The term includes a cardiac catheterization suite, a laser suite, and an endoscopy suite. It does not include a patient ' s room, a minor treatment room, a recovery room, or an ICU (unless the patient ' s condition was so critical that there would be insuf fi cient time for transportation to an OR).\nIf a less extensive procedure fails and a more extensive procedure is required, the second procedure is payable separately.\nprocedures that may be expected more commonly to be performed during the same session.\nIf the procedure is done as part of multiple procedures at the same time or day, a 51 modi fi er is used to note the distinct procedure, which indicates that multiple procedures were performed at the same session. That is, it applies to different procedures performed at the same session (example: thoracentesis and bronchoscopy on the same day).\nModi fi er 59 is used for a distinct procedural service. Modi fi er 59 indicates that a procedure is separate and distinct from another procedure on the same date of service. Typically, this modi fi er is applied to a procedure code that ordinarily is not paid separately from the fi rst procedure but should be paid per the speci fi cs of the situation. Example: Modi fi er 59 is applied when separate biopsies are performed on different anatomic sites or lesions during the same procedure or separate incision or different session\nThe 26 modi fi er is used when one needs to separate out the professional from the facility-based technical component of a procedure. Examples used in this section are of ultrasound imaging where clinical decisions are interpreted and made based on the image; however, the facility owns the equipment.\nModi fi er 22 is used for a procedure that is more complex than typical and represents substantially increased time to perform the service. It rarely is reimbursed and is carrier-dependent.\nModi fi er 50 is used for bilateral procedures that are not described inherently as bilateral. This would apply to bilateral indwelling pleural catheter and bilateral chest tubes as examples. Table 3 provides the CPT code descriptors for moderate sedation and common modi fi ers used for pleural procedures and their associated wRVUs",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "oderate Sedation",
      "content": "If moderate sedation is used for any pleural procedure and is administered under the direction of the operator or by a member of the operator ' s practice, there are time-based codes applied. For patients $ 5 years old, the fi rst 15 minutes of sedation is coded as 99152. A minimum time of 10 minutes must be reached to use this code. For each additional 15 minutes (a minimum of 8 minutes), the code 99153 is used. Note that the physician wRVU of 0.25 is for the fi rst 15 minutes, and the subsequent intervals are only practice expense. Further, the time is from the fi rst infusion of sedation to the end of 1:1 operator presence and may overlap but is not the same as procedure time. These codes do not apply if the sedation is administered by a practitioner from a separate group or specialty (ie, anesthesiologist).",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "onclusion",
      "content": "Although the clinical utility of pleural procedures is accepted more widely, the coding remains confusing due\nN/A = not applicable. See Table 1 legend for expansion of other abbreviation.\na Note that the physician wRVU of 0.25 is for the fi rst 15 minutes, and the subsequent intervals are only practice expense.\n\nto procedure complexity and updated coding requirements. The range of procedures discussed may be performed as stand-alone procedures but more commonly are performed along with advanced pulmonary or interventional pulmonary procedures. With improved technology, ef fi ciency, and ef fi cacy of performing multiple procedures in the same setting, it becomes critical to thoroughly understand the clinical, coding, and fi nancial implications of these procedures. Appropriately optimizing facility and physician reimbursement is integral to the assimilation of pleural procedures into comprehensive pulmonary and oncology programs.",
      "category": "conclusion",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "cknowledgments",
      "content": "Financial/non fi nancial disclosures: The authors have reported to CHEST the following: N. R. D. receives funding from Veran Medical, Level Ex, Boston scienti fi c (consultant). None declared (K. D. F. and K. L. K.).",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "eferences",
      "content": "1. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med . 2000;162(5):1987-2001.\n2. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; Group BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii32-ii40.\n3. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest . 2000;117(1):7378.\n4. Bielsa S, Salud A, Martinez M, et al. Prognostic signi fi cance of pleural fl uid data in patients with malignant effusion. Eur J Intern Med . 2008;19(5):334-339.\n5. Pilling JE, Dusmet ME, Ladas G, Goldstraw P. Prognostic factors for survival after surgical palliation of malignant pleural effusion. J Thorac Oncol . 2010;5(10):1544-1550.\n6. Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax . 2014;69(12):1098-1104.\n7. ( AMA) AMA. CPT 0 (Current Procedural Terminology). In: https://www.ama-assn.org/amaone/cpt-current-proceduralterminology. Accessed May 13, 2020.\n8. ( AMA) AMA. RVS Update Committee (RUC): RBRVS overview. https://www.ama-assn.org/about/rvs-update-committee-ruc/rbrvsoverview. Accessed May 31, 2020.\n9. Youse fi fard M, Baikpour M, Ghelichkhani P, et al. Screening performance characteristic of ultrasonography and radiography in detection of pleural effusion; a meta-analysis. Emergency . 2016;4(1): 1-10.\n10. Eibenberger KL, Dock WI, Ammann ME, Dorffner R, Hormann MF, Grabenwoger F. Quanti fi cation of pleural effusions: sonography versus radiography. Radiology . 1994;191(3):681-684.\n11. Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest . 2003;123(2):436-441.\n12. Raptopoulos V, Davis LM, Lee G, Umali C, Lew R, Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol . 1991;156(5):917-920.\n13. Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med . 2010;170(4):332-339.\n14. Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA, Ryu JH. Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound . 2005;33(9):442-446.\n15. Sachdeva A, Shepherd RW, Lee HJ. Thoracentesis and thoracic ultrasound: state of the art in 2013. Clin Chest Med . 2013;34(1):1-9.\n16. Cantey EP, Walter JM, Corbridge T, Barsuk JH. Complications of thoracentesis: incidence, risk factors, and strategies for prevention. Curr Opin Pulm Med . 2016;22(4):378-385.\n17. Puchalski JT, Argento AC, Murphy TE, Araujo KL, Pisani MA. The safety of thoracentesis in patients with uncorrected bleeding risk. Ann Am Thorac Soc . 2013;10(4):336-341.\n18. Zalt MB, Bechara RI, Parks C, Berkowitz DM. Effect of routine clopidogrel use on bleeding complications after ultrasound-guided thoracentesis. J Bronchology Interv Pulmonol . 2012;19(4):284-287.\n19. Baumann MH. Closed pleural biopsy: not dead yet! Chest . 2006;129(6):1398-1400.\n20. Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical-in the management of pleural diseases. J Thorac Dis . 2015;7(suppl4):S339S351.\n21. Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis . 2017;9(suppl10): S1111-S1122.\n22. Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii54-ii60.\n23. Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest . 2005;127(3):909-915.\n24. Hooper C, Lee YC, Maskell N; Group BTS Pleural Disease Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010;65(suppl2):ii4-ii17.\n25. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fl uid in the diagnosis of malignant mesothelioma. Chest . 1997;111(1):106-109.\n26. Shojaee S, Voelkel N, Farkas L, de Wit M, Lee HJ. Transforming growth factor-beta1 rise in pleural fl uid after tunneled pleural catheter placement: pilot study. J Bronchology Interv Pulmonol . 2013;20(4):304-308.\n27. CMS. Global Surgery Booklet. https://www.cms.gov/Regulationsand-Guidance/Guidance/Manuals/Downloads/clm104c12.pdf; 2018. Accessed May 30, 2020.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    }
  ],
  "tables_markdown": [
    "**{'cref': '#/texts/51'}**\n\n| Current Procedural Terminology Code | Code Description | wRVU |\n| --- | --- | --- |\n| 32554 | Thoracentesis, needle or catheter, aspiration of the pleural space; without imaging guidance | 1.82 |\n| 32555 | Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance | 2.27 |\n| 32556 | Pleural drainage, percutaneous, with insertion of indwelling catheter; without imaging guidance | 2.50 |\n| 32557 | Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance | 3.12 |\n| 32551 | Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure) | 3.04 |\n| 32550 | Insertion of indwelling tunneled pleural catheter with cuff | 3.92 |\n| 32552 | Removal of indwelling tunneled pleural catheter with cuff | 2.53 |\n| 32601 | Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy | 5.50 |\n| 32609 | Thoracoscopy; with biopsy(ies) of pleura | 4.58 |\n| 32650 | Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical) | 10.83 |\n| 32651 | Thoracoscopy, surgical; with partial pulmonary decortication | 18.78 |\n| 32653 | Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit | 18.17 |\n| 32561 | Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); initial day | 1.39 |\n| 32562 | Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); subsequent day | 1.24 |\n| 32400 | Biopsy, pleura, percutaneous needle | 1.76 |",
    "**{'cref': '#/texts/68'}**\n\n| CPT Code | Code Description | Global Period |\n| --- | --- | --- |\n| 32601 | Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy | 000 |\n| 32609 | Thoracoscopy; with biopsy(ies) of pleura | 000 |\n| 32650 | Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical) | 090 |\n| 32651 | Thoracoscopy, surgical; with partial pulmonary decortication | 090 |\n| 32653 | Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit | 090 |",
    "**{'cref': '#/texts/90'}**\n\n| Current Procedural Terminology Code | Description | wRVU |\n| --- | --- | --- |\n| 99152 | Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age $ 5 years | 0.25 |\n| 99153 | Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | N/A a |\n| Modi fi ers |  |  |\n| 26 | Modi fi er applied to 76604, 75989 if facility-owned ultrasound equipment used |  |\n| 25 | Modi fi er applied to same day ' Evaluation and Management ' |  |\n| 51 | Modi fi er for ' Additional Procedures ' done at same time |  |\n| 59 | Modi fi er for ' Distinct Procedural Service ' |  |"
  ],
  "tables_struct": [
    {
      "current_procedural_terminology_code": "32554",
      "code_description": "Thoracentesis, needle or catheter, aspiration of the pleural space; without imaging guidance",
      "wrvu": "1.82"
    },
    {
      "current_procedural_terminology_code": "32555",
      "code_description": "Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance",
      "wrvu": "2.27"
    },
    {
      "current_procedural_terminology_code": "32556",
      "code_description": "Pleural drainage, percutaneous, with insertion of indwelling catheter; without imaging guidance",
      "wrvu": "2.50"
    },
    {
      "current_procedural_terminology_code": "32557",
      "code_description": "Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance",
      "wrvu": "3.12"
    },
    {
      "current_procedural_terminology_code": "32551",
      "code_description": "Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)",
      "wrvu": "3.04"
    },
    {
      "current_procedural_terminology_code": "32550",
      "code_description": "Insertion of indwelling tunneled pleural catheter with cuff",
      "wrvu": "3.92"
    },
    {
      "current_procedural_terminology_code": "32552",
      "code_description": "Removal of indwelling tunneled pleural catheter with cuff",
      "wrvu": "2.53"
    },
    {
      "current_procedural_terminology_code": "32601",
      "code_description": "Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy",
      "wrvu": "5.50"
    },
    {
      "current_procedural_terminology_code": "32609",
      "code_description": "Thoracoscopy; with biopsy(ies) of pleura",
      "wrvu": "4.58"
    },
    {
      "current_procedural_terminology_code": "32650",
      "code_description": "Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical)",
      "wrvu": "10.83"
    },
    {
      "current_procedural_terminology_code": "32651",
      "code_description": "Thoracoscopy, surgical; with partial pulmonary decortication",
      "wrvu": "18.78"
    },
    {
      "current_procedural_terminology_code": "32653",
      "code_description": "Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit",
      "wrvu": "18.17"
    },
    {
      "current_procedural_terminology_code": "32561",
      "code_description": "Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); initial day",
      "wrvu": "1.39"
    },
    {
      "current_procedural_terminology_code": "32562",
      "code_description": "Instillation(s), via chest tube/catheter, agent for fi brinolysis (eg, fi brinolytic agent for break up of multiloculated effusion); subsequent day",
      "wrvu": "1.24"
    },
    {
      "current_procedural_terminology_code": "32400",
      "code_description": "Biopsy, pleura, percutaneous needle",
      "wrvu": "1.76"
    },
    {
      "cpt_code": "32601",
      "code_description": "Thoracoscopy, diagnostic (separate procedure); lungs, pericardial sac, mediastinal or pleural space, without biopsy",
      "global_period": "000"
    },
    {
      "cpt_code": "32609",
      "code_description": "Thoracoscopy; with biopsy(ies) of pleura",
      "global_period": "000"
    },
    {
      "cpt_code": "32650",
      "code_description": "Thoracoscopy, surgical; with pleurodesis (eg, mechanical or chemical)",
      "global_period": "090"
    },
    {
      "cpt_code": "32651",
      "code_description": "Thoracoscopy, surgical; with partial pulmonary decortication",
      "global_period": "090"
    },
    {
      "cpt_code": "32653",
      "code_description": "Thoracoscopy, surgical; with removal of intrapleural foreign body or fi brin deposit",
      "global_period": "090"
    },
    {
      "current_procedural_terminology_code": "99152",
      "description": "Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age $ 5 years",
      "wrvu": "0.25"
    },
    {
      "current_procedural_terminology_code": "99153",
      "description": "Moderate sedation services provided by the same physician or other quali fi ed health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient ' s level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service)",
      "wrvu": "N/A a"
    },
    {
      "current_procedural_terminology_code": "Modi fi ers",
      "description": "",
      "wrvu": ""
    },
    {
      "current_procedural_terminology_code": "26",
      "description": "Modi fi er applied to 76604, 75989 if facility-owned ultrasound equipment used",
      "wrvu": ""
    },
    {
      "current_procedural_terminology_code": "25",
      "description": "Modi fi er applied to same day ' Evaluation and Management '",
      "wrvu": ""
    },
    {
      "current_procedural_terminology_code": "51",
      "description": "Modi fi er for ' Additional Procedures ' done at same time",
      "wrvu": ""
    },
    {
      "current_procedural_terminology_code": "59",
      "description": "Modi fi er for ' Distinct Procedural Service '",
      "wrvu": ""
    }
  ],
  "references": [
    {
      "title": "Management of malignant pleural effusions"
    },
    {
      "title": "Am J Respir Crit Care Med",
      "year": 2000
    },
    {
      "title": "Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline",
      "year": 2000
    },
    {
      "title": "Thorax"
    },
    {
      "title": "Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease"
    },
    {
      "title": "Chest",
      "year": 2000
    },
    {
      "title": "Prognostic significance of pleural fluid data in patients with malignant effusion",
      "year": 2000
    },
    {
      "title": "Eur J Intern Med",
      "year": 2008
    },
    {
      "title": "Prognostic factors for survival after surgical palliation of malignant pleural effusion",
      "year": 2008
    },
    {
      "title": "J Thorac Oncol",
      "year": 2010
    },
    {
      "title": "Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score",
      "year": 2010
    },
    {
      "title": "Current Procedural Terminology)",
      "year": 2014
    },
    {
      "title": "RVS Update Committee (RUC): RBRVS overview"
    },
    {
      "title": "Screening performance characteristic of ultrasonography and radiography in detection of pleural effusion; a meta-analysis"
    },
    {
      "title": "Emergency",
      "year": 2016
    },
    {
      "title": "Quantification of pleural effusions: sonography versus radiography",
      "year": 2016
    },
    {
      "title": "Radiology",
      "year": 1994
    },
    {
      "title": "Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound",
      "year": 1994
    },
    {
      "title": "Factors affecting the development of pneumothorax associated with thoracentesis",
      "year": 2003
    },
    {
      "title": "AJR Am J Roentgenol",
      "year": 1991
    },
    {
      "title": "Pneumothorax following thoracentesis: a systematic review and meta-analysis",
      "year": 1991
    },
    {
      "title": "Arch Intern Med",
      "year": 2010
    },
    {
      "title": "Sonographically guided thoracentesis and rate of pneumothorax",
      "year": 2010
    },
    {
      "title": "J Clin Ultrasound",
      "year": 2005
    },
    {
      "title": "Thoracentesis and thoracic ultrasound: state of the art in 2013",
      "year": 2005
    },
    {
      "title": "Clin Chest Med",
      "year": 2013
    },
    {
      "title": "Complications of thoracentesis: incidence, risk factors, and strategies for prevention",
      "year": 2013
    },
    {
      "title": "Curr Opin Pulm Med",
      "year": 2016
    },
    {
      "title": "The safety of thoracentesis in patients with uncorrected bleeding risk",
      "year": 2016
    },
    {
      "title": "Ann Am Thorac Soc",
      "year": 2013
    },
    {
      "title": "Effect of routine clopidogrel use on bleeding complications after ultrasound-guided thoracentesis",
      "year": 2013
    },
    {
      "title": "J Bronchology Interv Pulmonol",
      "year": 2012
    },
    {
      "title": "Closed pleural biopsy: not dead yet!",
      "year": 2012
    },
    {
      "title": "Thoracoscopy: medical versus surgical-in the management of pleural diseases",
      "year": 2006
    },
    {
      "title": "J Thorac Dis",
      "year": 2015
    },
    {
      "title": "Diagnosis and management of malignant pleural effusions: state of the art in 2017",
      "year": 2015
    },
    {
      "title": "Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline",
      "year": 2017
    },
    {
      "title": "Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion"
    },
    {
      "title": "Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline",
      "year": 2005
    },
    {
      "title": "The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma"
    },
    {
      "title": "Transforming growth factor-beta1 rise in pleural fluid after tunneled pleural catheter placement: pilot study",
      "year": 1997
    },
    {
      "title": "Global Surgery Booklet",
      "year": 2013
    }
  ]
}